Zimmer Biomet Holdings, Inc.
ZBHNYSEHealthcare● Active
$88.05
+$0.72(+0.82%)
Market Cap$17.0B
P/E Ratio—
52W High$108.29
52W Low$79.12
Zimmer Biomet Holdings, Inc. (ZBH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ZBH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Cost of Revenue | $3.16B | $2.19B | $2.08B | $2.02B | $1.96B |
| Gross Profit | $5.07B | $5.49B | $5.31B | $4.92B | $4.87B |
| Gross Margin %(computed) | 61.62% | 71.46% | 71.82% | 70.90% | 71.29% |
| Operating Expenses | |||||
| R&D Expenses | $0.46B | $0.44B | $0.46B | $0.41B | $0.44B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $3.71B | $4.20B | $4.03B | $4.22B | $4.01B |
| Operating Income | $1.36B | $1.29B | $1.28B | $0.70B | $0.86B |
| Operating Margin %(computed) | 16.55% | 16.74% | 17.28% | 10.03% | 12.60% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.29B | $0.22B | $0.20B | $0.16B | $0.21B |
| Income Before Tax | $0.83B | $1.04B | $1.07B | $0.40B | $0.50B |
| Income Tax Expense | $0.13B | $0.13B | $0.04B | $0.11B | $0.05B |
| Net Income | $0.71B | $0.90B | $1.02B | $0.23B | $0.40B |
| Net Margin %(computed) | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 |
| Wtd Avg Shares | 0.20B | 0.20B | 0.21B | 0.21B | 0.21B |
| EBITDA | $2.22B | $2.25B | $2.22B | $1.49B | $1.65B |
| EBITDA Margin %(computed) | 26.94% | 29.31% | 30.03% | 21.54% | 24.10% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Zimmer Biomet Holdings, Inc. data
About Zimmer Biomet Holdings, Inc. (ZBH) Income Statement
Zimmer Biomet Holdings, Inc. (ZBH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ZBH reported revenue of $8.23B, gross profit of $5.07B (gross margin 61.62%), and net income of $0.71B — a net profit margin of 8.57%.
Frequently asked questions
ZBH · 4 questionsZimmer Biomet Holdings, Inc. (ZBH) reported revenue of $8.23B for 2025, up 7.2% year-over-year.
ZBH revenueZBH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08